Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:17629517  

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Manish J Butte | Mary E Keir | Theresa B Phamduy | Arlene H Sharpe | Gordon J Freeman
Immunity | 2007

Pathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tolerance. B7-dependent responses in Cd28(-/-)Ctla4(-/-) T cells together with reports of stimulatory and inhibitory functions for Programmed Death-1 Ligand 1 or 2 molecules (PD-L1 or PD-L2) have suggested additional receptors for these B7 family members. We show that B7-1 and PD-L1 interacted with affinity intermediate to that of B7-1:CD28 and B7-1:CTLA-4. The PD-L1:B7-1 interface overlapped with the B7-1:CTLA-4 and PD-L1:PD-1 (Programmed Death-1) interfaces. T cell activation and cytokine production were inhibited by the interaction of B7-1 with PD-L1. The responses of PD-1-deficient versus PD-1,B7-1 double-deficient T cells to PD-L1 and of CD28,CTLA-4 double-deficient versus CD28,CTLA-4,PD-L1 triple-deficient T cells to B7-1 demonstrated that PD-L1 and B7-1 interact specifically to inhibit T cell activation. Our findings point to a substantial bidirectional inhibitory interaction between B7-1 and PD-L1 and add an additional dimension to immunoregulatory functions of the B7:CD28 family.

Pubmed ID: 17629517

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040614-05
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI056299-05
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI056299
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040614-06
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI056299-04
  • Agency: NIAID NIH HHS, United States
    Id: R37 AI038310
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI038310-06
  • Agency: NCRR NIH HHS, United States
    Id: S10RR017948-01A1
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040614
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI038310-07
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI38310
  • Agency: NCRR NIH HHS, United States
    Id: S10 RR017948
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI038310
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI56299
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI038310-05
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI46414
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040614-07

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions